Latigo Bio Stock
Latigo Bio is focused on developing innovative non-opioid pain medicines with best-in-class profiles. Their goal is to provide effective, rapid-acting pain relief by targeting pain at its source, without the risk of addiction.
Sign up for SecondMarket™ to view the market and buy or sell Latigo Bio Stock
Buy + SellSee Latigo Bio Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Latigo Bio Stock Valuation + Share Prices
View real-time Tape D™ data on Latigo Bio stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedLatigo Bio Management Team
Director
Tim Walbert
CEO, Director
Nima Farzan
CFO
Tim Lugo
Director
Deborah Palestrant
Director
Nancy Stagliano
Director
Kevin Raidy
Director
Jim Tananbaum
Director
Beth Seidenberg
Latigo Bio Major Investors
Access Biotechnology
Kern Capital
5AM Ventures
Deep Track Capital
UPMC Enterprises
Rock Springs Capital
Cormorant Asset Management
Sanofi Ventures
Westlake Village BioPartners
Corner Ventures
Alexandria Venture Investments
Blue Owl Capital
Qatar Investment Authority (QIA)
Foresite Capital
Learn More About Latigo Bio Stock
Buy Latigo Bio Stock
01Latigo Bio stock does not trade on public stock exchanges. Latigo Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Latigo Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Latigo Bio Stock
02Latigo Bio Stock does not trade on public stock exchanges. In order to sell Latigo Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Latigo Bio Stock Price
03Latigo Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Latigo Bio share price and other valuable private market data.
Read more about secondary market private company stock prices:
Latigo Bio Stock Ticker Symbol
04There is no ticker symbol for Latigo Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Latigo Bio Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Latigo Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Latigo Bio Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Latigo Bio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Latigo Bio Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Latigo Bio IPO
08Latigo Bio is a private company and has not had an IPO. There is currently no Latigo Bio IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Latigo Bio IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Latigo Bio Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.